Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TBPHTBPH
Showing 6 of 9 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in THERAVANCE BIOPHARMA INC

Qube Research & Technologies Ltd holds 429,813 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $7.3M as of 2026-Q2. The position was increased (+48.5% shares). TBPH represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$7.3M

Current Shares

429,813

Total Value Change

+$6.3M

Total Shares Change

+315,874

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
429,813
+48.5%
$7.3M0.0%$17.00
38
2026-Q1
Decreased
289,473
-38.9%
$4.7M0.0%$13.96
0
2025-Q4
Increased
473,498
+124.4%
$8.9M0.0%$18.91
44
2025-Q3
Increased
211,048
+2.8%
$3.1M0.0%$14.43
27
2025-Q2
Increased
205,280
+80.2%
$2.3M0.0%$11.22
40
2025-Q1
New
113,939
-
$1M0.0%$9.23
35

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used